Incorporating a generic model of subcutaneous insulin absorption into the AIDA v4 diabetes simulator 3. Early plasma insulin determinations

Journal of Diabetes Science and Technology

Volumn 3, Issue 1, 2009, Pages 190-201

  Lehmann, Eldon D ^a,b   Tarín, Cristina ^c   Bondia, Jorge ^d   Teufel, Edgar ^d   Deutsch, Tibor ^e  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b UNIVERSITY OF TORONTO   (Canada)

^c ITEAM RESEARCH INSTITUTE   (Spain)

^d UNIVERSITAT POLITÈCNICA DE VALÈNCIA   (Spain)

^e SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Absorption; Computer; Diabetes; Insulin; Model; Simulation; Software

Indexed keywords

INSULIN;

ARTICLE; BLOOD; COMPUTER SIMULATION; DIABETES MELLITUS; HUMAN; INTERNET; SUBCUTANEOUS DRUG ADMINISTRATION;

COMPUTER SIMULATION; DIABETES MELLITUS; HUMANS; INJECTIONS, SUBCUTANEOUS; INSULIN; INTERNET;

EID: 79952721537     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229680900300123     Document Type: Article

References (35)

1. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977-86.
2. Lehmann ED, Deutsch T. A physiological model of glucose-insulin interaction. In: IEEE EMBS Proceedings, 13th Annual International Conference of the IEEE Engineering in Medicine and Biology Society. 1991;13(5):2274-5.
3. Lehmann ED, Deutsch T. A physiological model of glucose-insulin interaction in type I diabetes mellitus. J Biomed Eng. 1992;14(3):235-42.
4. Lehmann ED. Diabetes moves onto the Internet. Lancet. 1996;347:1542.
5. Lehmann ED. Development, evaluation, and usage of 'AIDA' - an interactive educational diabetes simulator. Ph.D. Thesis. University of London/Imperial College of Science, Technology and Medicine; 2004.
6. Lehmann ED, Chatu SS, Hashmy SSH. Retrospective pilot feedback survey of 200 users of the AIDA version 4 educational diabetes program. Diabetes Technol Ther. 2006;8(3):419-32
7. and 8(5):602-8.
8. Lehmann ED. Interactive educational simulators in diabetes care. Med Inform (Lond). 1997;22(1): 47-76.
9. Berger M, Rodbard D. Computer simulation of plasma insulin and glucose dynamics after subcutaneous insulin injection. Diabetes Care. 1989;12(10):725-36.
10. Sivitz WI, Davidson PC, Steed D, Bode B, Richardson P. Computer-assisted instruction in intense insulin therapy using a mathematical model for clinical simulation with a clinical algorithm and flow sheet. Diabetes Educ. 1989;15(1):77-9.
11. Hedbrant J, Ludvigsson J, Nordenskjöld K. Särimner: a computer model of diabetes physiology for education of physicians and patients. Diabetes Res Clin Pract. 1991;14(2):113-22.
12. Rutscher A, Salzsieder E, Fischer U. KADIS: model-aided education in type I diabetes. Karlsburg Diabetes Management System. Comput Methods Programs Biomed. 1994;41(3-4):205-15.
13. Plougmann S, Hejlesen OK, Cavan DA. DiasNet - a diabetes advisory system for communication and education via the internet. Int J Med Inform. 2001 Dec;64(2-3):319-30.
14. Lehmann ED. Usage of a diabetes simulation system for education via the Internet. Int J Med Inform. 2003;69(1):63-9.
15. Biermann E, Mehnert H. DIABLOG: a simulation program of insulin-glucose dynamics for education of diabetics. Comput Methods Programs Biomed. 1990;32(3-4):311-8.
16. Biermann E. DIACATOR: simulation of metabolic abnormalities of type II diabetes mellitus by use of a personal computer. Comput Methods Programs Biomed. 1994;41(3-4):217-29.
17. Lehmann ED, Deutsch T, Carson ER, Sonksen PH. AIDA: An Interactive Diabetes Advisor. Computer Methods Prog Biomed. 1994;41(3):183-203.
18. Lehmann ED, Hermanyi I, Deutsch T. Retrospective validation of a physiological model of glucose-insulin interaction in type 1 diabetes mellitus. Med Eng Phys. 1994;16(3):193-202 [Published erratum appears in Medical Eng Phys. 16(4):351-2].
19. Lehmann ED, Deutsch T, Carson ER, Sonksen PH. Combining rule-based reasoning and mathematical modelling in diabetes care. Artif Intell Med. 1994;6(2):137-60.
20. Tarín C, Teufel E, Picó J, Bondia J, Pfleiderer HJ. Comprehensive pharmacokinetic model of insulin Glargine and other insulin formulations. IEEE Trans Biomed Eng. 2005;52(12):1994-2005.
21. Tarín C, Bondia J, Teufel E, Vehí J. On spatial discretisation in the calculus of subcutaneous insulin absorption profiles. In: Proceedings of the 2nd European Modeling and Simulation Symposium (EMSS). Spain: Barcelona; 2006. p 379-84.
22. Lehmann ED, Tarín C, Bondia J, Teufel E, Deutsch T. Incorporating a generic model of subcutaneous insulin absorption into the AIDA v4 diabetes simulator. 1. A prospective collaborative development plan. J Diabetes Sci Technol. 2007;1(3):423-35.
23. Lehmann ED, Tarín C, Bondia J, Teufel E, Deutsch T. Incorporating a generic model of subcutaneous insulin absorption into the AIDA v4 diabetes simulator. 2. Preliminary bench testing. J Diabetes Sci Technol. 2007;1(5):780-93.
24. Bergenstal RM. Effective insulin therapy. In: DeFronzo RA, Ferrannini E, Keen H, Zimmet P, editors. International textbook of diabetes mellitus. 3rd ed. Chichester, UK: Wiley; 2004. p 995-1015.
25. Lehmann ED, Deutsch T. Open access availability of AIDA v4.3a diabetes simulator Turbo Pascal source code for non-commercial use [abstract]. J Diabetes Sci Technol. 2007;1(2):A86.
26. Nucci G, Cobelli C. Models of subcutaneous insulin kinetics. A critical review. Comput Methods Prog Biomed. 2000;62(3):249-57.
27. Lepore M, Pampanelli S, Fanelli C, Porcellati F, Bartocci L, Di Vincenzo A, Cordoni C, Costa E, Brunetti P, Bolli GB. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes. 2000;49(12):2142-8.
28. Whittingham JL, Havelund S, Jonassen I. Crystal structure of a prolonged-acting insulin with albumin-binding properties. Biochemistry. 1997;36(10):2826-31.
29. Kurtzhals P, Havelund S, Jonassen I, Kiehr B, Larsen UD, Ribel U, Markussen J. Albumin binding of insulins acylated with fatty acids: characterization of the ligand-protein interaction and correlation between binding affinity and timing of the insulin effect in vivo. Biochem J. 1995;312(Pt 3):725-31.
30. Zib I, Raskin P. Novel insulin analogues and its mitogenic potential. Diabetes Obes Metab. 2006;8(6):611-20.
31. Dea MK, Hamilton-Wessler M, Ader M, Moore D, Schäffer L, Loftager M, Vølund A, Bergman RN. Albumin binding of acylated insulin (NN304) does not deter action to stimulate glucose uptake. Diabetes. 2002;51(3):762-9.
32. Hamilton-Wessler M, Ader M, Dea M, Moore D, Jorgensen PN, Markussen J, Bergman RN. Mechanism of protracted metabolic effects of fatty acid acylated insulin, NN304, in dogs: retention of NN304 by albumin. Diabetologia. 1999;42(10):1254-63.
33. Plank J, Bodenlenz M, Sinner F, Magnes C, Goerzer E, Regitting W, Endahl LA, Draeger E, Zdravkovic M, Pieber TR. A double-blind, randomized, dose-response study investigating the pharmacodynamic and pharmacokinetic properties of long-acting insulin analog detemir. Diabetes Care. 2005;28(5):1107-12.
34. Lehmann ED. Research use of the AIDA www.2aida. org diabetes software simulation program: a review. Diabetes Technol Ther. 2003;5(3):425-38
35. and 5(4):641-51.